These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents. Lu T; Drlica K J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961 [TBL] [Abstract][Full Text] [Related]
44. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity. Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154 [TBL] [Abstract][Full Text] [Related]
45. Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. Sanguinetti M; Ardito F; Fiscarelli E; La Sorda M; D'Argenio P; Ricciotti G; Fadda G J Clin Microbiol; 2001 Feb; 39(2):816-9. PubMed ID: 11158161 [TBL] [Abstract][Full Text] [Related]
46. [Chemo-antibiotic-resistance in vitro of "atypical" mycobacteria and Mycobacterium tuberculosis]. Caroli G; Spaziante G; Mazzarone R Riv Ital Ig; 1966; 26(5):535-46. PubMed ID: 4967922 [No Abstract] [Full Text] [Related]
47. Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility. Uslan DZ; Kowalski TJ; Wengenack NL; Virk A; Wilson JW Arch Dermatol; 2006 Oct; 142(10):1287-92. PubMed ID: 17043183 [TBL] [Abstract][Full Text] [Related]
48. The thuggacins, novel antibacterial macrolides from Sorangium cellulosum acting against selected Gram-positive bacteria. Irschik H; Reichenbach H; Höfle G; Jansen R J Antibiot (Tokyo); 2007 Dec; 60(12):733-8. PubMed ID: 18276996 [TBL] [Abstract][Full Text] [Related]
52. Treatment of disease caused by nontuberculous mycobacteria. Bass JB; Hawkins EL Arch Intern Med; 1983 Jul; 143(7):1439-41. PubMed ID: 6870414 [TBL] [Abstract][Full Text] [Related]
53. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria. Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064 [TBL] [Abstract][Full Text] [Related]
54. [Pulmonary infection by Mycobacterium malmoense in a patient with AIDS]. López R; Redondo MP; Ruiz D; Geijo P Enferm Infecc Microbiol Clin; 1997 Jan; 15(1):47-8. PubMed ID: 9147514 [No Abstract] [Full Text] [Related]
55. The diagnosis of two cases of cutaneous ulcer caused by infection with Mycobacterium haemophilum: direct identification in a clinical sample by polymerase chain reaction-restriction endonuclease analysis. Da Mata O; Pérez Alfonzo R; Natera I; Sucre Rdel C; Bello T; de Waard JH Int J Dermatol; 2008 Aug; 47(8):820-3. PubMed ID: 18717862 [TBL] [Abstract][Full Text] [Related]
56. Usefulness of the Etest for studying tigecycline susceptibility of non-pigmented rapidly growing mycobacteria. Martín-de-Hijas NZ; Fernández-Roblas R; Fernandez-Martínez AI; Gadea I; Esteban J Int J Antimicrob Agents; 2008 Oct; 32(4):366-7. PubMed ID: 18572391 [No Abstract] [Full Text] [Related]
57. [Isoxyl and T283 in the treatment of photochromogenic infections in mice]. Burjanová B; Dornetzhuber V Z Tuberk Erkr Thoraxorg; 1967; 127(1):123-5. PubMed ID: 5632189 [No Abstract] [Full Text] [Related]
58. [Quality control of culture media for mycobacterium drug sensitivity tests]. Kekkaku; 2003 Aug; 78(8):563-8. PubMed ID: 14582504 [No Abstract] [Full Text] [Related]